MSB 1.86% $1.32 mesoblast limited

MSB - A Question of Trust?, page-246

  1. 4,959 Posts.
    lightbulb Created with Sketch. 782
    Yes, it’s funny how many small medical treatment companies have managed to obtain full approvals for their products. Amazing really.

    The devotees work themselves up into a rich lather over the rejection of the cancer application because they failed to undertake proper trials and instead elected to go down the “big wig” promotion course. Regardless of the strong hints from the FDA that trials were needed.

    Then, there’s the failure to obtain an EUA for the Covid application. There’s a bunch of posters distasteful counting of fatalities as some sort of internal justification. But, never a question is raised about Novartis disappearing off the face of the MSB earth, or the fact there is no EUA for a alleged miracle cure in the biggest health crisis in 100 years.

    If your not approved an EUA in those circumstances, then forget it. Rather, the FDA says go and do a trial. There’s confidence.

    Oh yes, it’s much better to chant “big announcement is due” over and over again.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.